Related references
Note: Only part of the references are listed.Multiplicity considerations for subgroup analysis subject to consistency constraint
Mohamed Alosh et al.
BIOMETRICAL JOURNAL (2013)
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Guiquan Jia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Randomized Phase II Trial Designs With Biomarkers
Boris Freidlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung Cancer
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Randomized Clinical Trials With Biomarkers: Design Issues
Boris Freidlin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Experience with reviewing Bayesian medical device trials
Gene Pennello et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2008)
Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset
Sue-Jane Wang et al.
PHARMACEUTICAL STATISTICS (2007)
Use of genomic signatures in therapeutics development in oncology and other diseases
R. Simon et al.
PHARMACOGENOMICS JOURNAL (2006)
Share Paper
